Moderna says COVID-19 vaccine ‘highly effective’ in preventing illness in teens

Shares of COVID-19 vaccine maker Moderna Inc (NASDAQ: MRNA) were trading higher by more than 2% Tuesday morning after announcing encouraging results from its TeenCOVE study. Study results Moderna said in a press release its Phase ⅔ study of its COVID-19 vaccine (mRNA-1273) in adolescents met its primary immunogenicity endpoint. Specifically, there were zero confirmed […]